A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
THREE-YEAR FOLLOW-UP RESULTS OF THE FIRST CLINICAL STUDY ON THE DAILY AND TWICE-WEEKLY ADMINISTRATIONS OF R I F A M PICIN, INVESTIGATED BY THE T U B E RCULOSIS
Tuberculosis Research Committee, RYOKEN, had carried out a clinical trial as to the therapeutic effects of RFP on retreatment cases of pulmonary tuberculosis from June, 1969, and the patients of this trial were followed up at three years interval after the beginning of the trial. At the start of the trial, all patients were divided into two groups. Patients of the group I had been treated previously by various antituberculosis drugs including EB, and RFP was administered daily together with thedoi:10.11400/kekkaku1923.49.4_107 fatcat:uercrwichfdafmjtjfvfiicbe4